X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Parmax Pharma Ltd.
BSE CODE: 540359   |   NSE CODE: NA   |   ISIN CODE : INE240T01014   |   09-Jan-2026 Hrs IST
BSE NSE
Rs. 39.18
2.19 ( 5.92% )
 
Prev Close ( Rs.)
36.99
Open ( Rs.)
36.99
 
High ( Rs.)
40.00
Low ( Rs.)
33.06
 
Volume
6170
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-5.60  -15.37  -0.28  0.38  2.02  
   CEPS(Rs)-2.84  -10.80  4.74  5.54  7.21  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-7.21  -1.62  12.70  11.92  10.48  
   Tax Rate(%)12.57  -1.67  325.63  53.34  37.57  
Margin Ratios          
   Core EBITDA Margin(%)0.90  -30.48  14.64  14.02  13.04  
   EBIT Margin(%)-6.42  -45.53  2.72  3.78  5.97  
   Pre Tax Margin(%)-8.49  -51.17  0.30  1.66  4.61  
   PAT Margin (%)-7.42  -52.03  -0.67  0.78  2.88  
   Cash Profit Margin (%)-3.77  -36.54  11.50  11.36  10.29  
Performance Ratios          
   ROA(%)-12.36  -34.91  -0.58  0.70  3.45  
   ROE(%)0.00  -277.44  -2.26  3.38  22.55  
   ROCE(%)-29.88  -59.76  3.96  6.62  16.25  
   Asset Turnover(x)1.66  0.67  0.87  0.90  1.20  
   Sales/Fixed Asset(x)1.50  0.58  0.86  1.09  2.05  
   Working Capital/Sales(x)-9.29  -3.21  39.33  -24.19  -28.92  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.67  1.73  1.16  0.91  0.49  
   Receivable days20.01  40.27  15.38  23.31  34.54  
   Inventory Days36.94  110.64  84.70  68.05  46.50  
   Payable days149.20  311.96  338.42  419.72  265.42  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  108.01  17.60  
   PCE(x)-14.88  -2.64  6.40  7.37  4.93  
   Price/Book(x)-5.86  -17.63  2.39  3.43  3.39  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)0.84  1.49  1.06  1.06  0.63  
   EV/Core EBITDA(x)80.88  -4.97  7.10  7.40  4.74  
   EV/EBIT(x)-13.15  -3.28  38.94  28.12  10.63  
   EV/CE(x)3.90  2.75  1.51  1.08  0.73  
   M Cap / Sales0.56  0.96  0.74  0.84  0.51  
Growth Ratio          
   Net Sales Growth(%)155.17  -28.23  -15.57  -30.31  25.13  
   Core EBITDA Growth(%)108.86  -244.53  -12.38  -25.19  87.60  
   EBIT Growth(%)64.05  -1300.54  -39.28  -55.86  81.55  
   PAT Growth(%)63.59  -5425.72  -173.54  -81.24  75.99  
   EPS Growth(%)63.59  -5424.95  -173.55  -81.24  75.99  
Financial Stability Ratios          
   Total Debt/Equity(x)-4.07  56.07  0.98  1.00  1.27  
   Current Ratio(x)0.77  0.63  1.05  0.90  0.92  
   Quick Ratio(x)0.51  0.37  0.45  0.51  0.57  
   Interest Cover(x)-3.09  -8.08  1.12  1.78  4.40  
   Total Debt/Mcap(x)0.51  0.55  0.47  0.34  0.44